Single-nucleus transcriptome-wide association study of human brain disorders

Sanan Venkatesh,Zhenyi Wu,Marios Anyfantakis,Christian Dillard,Prashant N M,David Burstein,Deepika Mathur,Roman Kosoy,Christos Chatzinakos,Bukola Ajanaku,Fotis Tsetsos,Biao Zeng,Aram Hong,Clara Casey,Marcela Alvia,Zhiping Shao,Stathis Argyriou,Karen Therrien,VA Million Veteran Program,PsychAD Consortium,Tim Bigdeli,Pavan Auluck,David A Bennett,Stefano Marenco,Vahram Haroutunian,Kiran Girdhar,Jaroslav Bendl,Donghoon Lee,John F Fullard,Gabriel E Hoffman,Georgios Voloudakis,Panos Roussos

DOI: https://doi.org/10.1101/2024.11.04.24316495

2024-11-05

Abstract:Neuropsychiatric and neurodegenerative disorders exhibit cell–type–specific characteristics , yet most transcriptome–wide association studies have been constrained by the use of homogenate brain tissue , limiting their resolution and power. Here, we present a single–nucleus transcriptome–wide association study (snTWAS) leveraging single–nucleus RNA sequencing of over 6 million nuclei from the dorsolateral prefrontal cortex of 1,494 donors across three ancestries–European, African, and Admixed American. We constructed ancestry–specific single–nucleus–derived transcriptomic imputation models (snTIMs) including up to 27 non–overlapping cellular populations, enhancing the resolution of genetically regulated gene expression (GReX) in the brain and uncovering novel gene–trait associations across 12 neuropsychiatric and neurodegenerative traits. Our snTWAS framework revealed cell–type–specific dysregulation of GReX, identifying over 4,000 novel gene–trait associations not detected by bulk tissue approaches. By applying these snTIMs to the Million Veteran Program, we validated major findings and explored the pleiotropy of cell–type–specific GReX, revealing cross–ancestry concordance and fine–mapping causal genes. This approach enhances the discovery of biologically relevant pathways and gene targets, highlighting the importance of cell–type resolution and ancestry–specific models in understanding the genetic architecture of complex brain disorders.

Genetic and Genomic Medicine

What problem does this paper attempt to address?

This paper aims to address the research limitations in cell - type - specific gene expression regulation in neuropsychiatric disorders (NPDs) and neurodegenerative diseases (NDDs). Specifically, most traditional transcriptome - wide association studies (TWAS) use mixed brain tissue samples, which limits their resolution and ability to accurately capture the gene expression characteristics of specific cell types and their genetic regulatory mechanisms. By leveraging single - nucleus RNA sequencing technology, this study constructed single - nucleus - derived transcriptome imputation models (snTIMs), covering as many as 27 non - overlapping cell populations, and analyzed them in three populations of different ancestries. This method not only improves the resolution of genetically regulated gene expression (GReX), but also reveals new gene - phenotype associations in 12 neuropsychiatric and neurodegenerative diseases that were not detected by traditional tissue - level methods. In addition, by applying these models to the data of the Million Veteran Program (MVP), the researchers verified the main findings and explored the pleiotropy of cell - type - specific GReX, revealing cross - ancestry consistency and fine - mapping of causal genes. In conclusion, this study emphasizes the importance of cell - type resolution and ancestry - specific models in understanding the genetic architecture of complex brain diseases.